Mikkel G. Terp

1.7k citations

42 papers · 1.2k indexed · 1 hit paper · h-index 19

Molecular Biology
Oncology top 10%
Cancer Research top 5%
Immunology top 10%
Pulmonary and Respiratory Medicine top 10%

Co-authors: Henrik J. Ditzel Rikke Leth‐Larsen Sidse Ehmsen Rikke Raaen Lund Ole N. Jensen Morten F. Gjerstorff B. Christoffer Lagerholm Eva C. Arnspang
Topics: Immunotherapy and Immune Responses (6 papers)RNA Interference and Gene Delivery (5 papers)Peptidase Inhibition and Analysis (4 papers)
Cited by: Cancer Research Physiology Oncology
Journals: Nucleic Acids Research Nature Communications The Journal of Experimental Medicine
Partner nations: Denmark Australia Sweden

In The Last Decade

Mikkel G. Terp

42 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neutrophil extracellular traps formed during chemotherapy confer treatment resistance via TGF-β activation

2023 148 citations Isabelle Bourget, Pascal Lopez et al. Cancer Cell profile →

Peers

Countries citing papers authored by Mikkel G. Terp

Since Specialization

Citations

This map shows the geographic impact of Mikkel G. Terp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikkel G. Terp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikkel G. Terp more than expected).

Fields of papers citing papers by Mikkel G. Terp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikkel G. Terp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikkel G. Terp. The network helps show where Mikkel G. Terp may publish in the future.

Co-authorship network of co-authors of Mikkel G. Terp

This figure shows the co-authorship network connecting the top 25 collaborators of Mikkel G. Terp. A scholar is included among the top collaborators of Mikkel G. Terp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikkel G. Terp. Mikkel G. Terp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Stochastic demethylation and redundant epigenetic suppressive mechanisms generate highly heterogeneous responses to pharmacological DNA methyltransferase inhibition 2025 ·Journal of Experimental & Clinical Cancer Research ·(unknown),Sofie Traynor,(unknown),Christina Dahl,Mette Stæhr,(unknown),Maria S. Madsen,Rasmus Siersbæk,Mikkel G. Terp,(unknown),Christina B. Pedersen,(unknown),Jonathan R. Brewer,Pascal H. G. Duijf,(unknown),Henrik J. Ditzel,Alexei F. Kirkin,Per Guldberg,Morten F. Gjerstorff	3
2	Gastrin-releasing peptide receptor as theranostic target in estrogen-receptor positive breast cancer: A preclinical study of the theranostic pair [55Co]Co- and [177Lu]Lu-DOTA-RM26 2024 ·Nuclear Medicine and Biology ·Christina Baun,Birgitte Brinkmann Olsen,Carla L. Alves,Henrik J. Ditzel,Mikkel G. Terp,Malene Grubbe Hildebrandt,Charlotte Aaberg Poulsen,(unknown),(unknown),Anna Orlova,Johan Hygum Dam,Helge Thisgaard	5
3	A novel multitargeted self-assembling peptide-siRNA complex for simultaneous inhibition of SARS-CoV-2-host cell interaction and replication 2024 ·Molecular Therapy — Nucleic Acids ·(unknown),(unknown),Mikkel G. Terp,(unknown),(unknown),(unknown),Niels Langkjær,(unknown),(unknown),(unknown),(unknown),(unknown)	6
4	Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis 2024 ·Molecular Cancer ·(unknown),Mikkel G. Terp,Alexei F. Kirkin,(unknown),Sofie Traynor,(unknown),Per Guldberg,Annette Raskov Kodahl,Morten F. Gjerstorff,Henrik J. Ditzel	9
5	Neutrophil extracellular traps formed during chemotherapy confer treatment resistance via TGF-β activationbreakdown → 2023 ·Cancer Cell ·(unknown),(unknown),Isabelle Bourget,Pascal Lopez,(unknown),Julien Cherfils‐Vicini,Chloé Dominici,Géraldine Rios,(unknown),Bodu Liu,David L. Spector,Sidse Ehmsen,Shufang Renault,Caroline Hego,Fatima Mechta‐Grigoriou,François‐Clément Bidard,Mikkel G. Terp,Mikala Egeblad,Cédric Gaggioli,Jean Albrengues	148
6	Targeting two distinct epitopes on human CD73 with a bispecific antibody improves anticancer activity 2022 ·Journal for ImmunoTherapy of Cancer ·(unknown),Mikkel G. Terp,(unknown),Aran F. Labrijn,(unknown),(unknown),(unknown),Søren Hansen,Morten F. Gjerstorff,Christa E. Müller,Paul W.H.I. Parren,Henrik J. Ditzel	9
7	DNA methyltransferase inhibition promotes recruitment of myeloid-derived suppressor cells to the tumor microenvironment through induction of tumor cell-intrinsic interleukin-1 2022 ·Cancer Letters ·Sofie Traynor,Mikkel G. Terp,(unknown),Per Guldberg,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Henrik J. Ditzel,Morten F. Gjerstorff	16
8	SSX addiction in melanoma propagates tumor growth and metastasis 2022 ·Frontiers in Oncology ·Sofie Traynor,(unknown),(unknown),Behzad Mansoori,Mikkel G. Terp,(unknown),(unknown),(unknown),Henrik J. Ditzel,Morten F. Gjerstorff	2
9	Co-targeting CDK2 and CDK4/6 overcomes resistance to aromatase and CDK4/6 inhibitors in ER+ breast cancer 2022 ·npj Precision Oncology ·(unknown),Carla L. Alves,Sidse Ehmsen,(unknown),Mikkel G. Terp,Lene E. Johansen,(unknown),(unknown),Daniel Eliáš,Martin Bak,Henrik J. Ditzel	47
10	The Cancer/Testis Antigen Gene VCX2 Is Rarely Expressed in Malignancies but Can Be Epigenetically Activated Using DNA Methyltransferase and Histone Deacetylase Inhibitors 2021 ·Frontiers in Oncology ·(unknown),Sofie Traynor,Mette Stæhr,(unknown),(unknown),Mikkel G. Terp,Christina B. Pedersen,Per Guldberg,Henrik J. Ditzel,Morten F. Gjerstorff	16
11	DDX56 modulates post-transcriptional Wnt signaling through miRNAs and is associated with early recurrence in squamous cell lung carcinoma 2021 ·Molecular Cancer ·Qingqing Wu,Xiaoyang Luo,Mikkel G. Terp,Qingrun Li,Yuan Li,Lei Shen,Ying Chen,Kirstine Jacobsen,Trever G. Bivona,Haiquan Chen,Rong Zeng,Henrik J. Ditzel	22
12	Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer 2021 ·Nature Communications ·Carla L. Alves,Sidse Ehmsen,Mikkel G. Terp,Neil Portman,(unknown),(unknown),(unknown),(unknown),Lene E. Johansen,Martin Bak,Gabriella Honeth,Ana Bosch,Elgene Lim,Henrik J. Ditzel	5
13	Enapotamab vedotin, an AXL-specific antibody-drug conjugate, shows preclinical antitumor activity in non-small cell lung cancer 2019 ·JCI Insight ·Louise A. Koopman,Mikkel G. Terp,Gijs G. Zom,Maarten L. Janmaat,Kirstine Jacobsen,(unknown),(unknown),Ulf Forssmann,(unknown),Nora Pencheva,Andreas Lingnau,M Zipeto,Paul W.H.I. Parren,Esther C.W. Breij,Henrik J. Ditzel	46
14	Increased Cholesterol Biosynthesis Is a Key Characteristic of Breast Cancer Stem Cells Influencing Patient Outcome 2019 ·Cell Reports ·Sidse Ehmsen,Martin H. Pedersen,Guisong Wang,Mikkel G. Terp,(unknown),Brian L. Hood,Thomas P. Conrads,Rikke Leth‐Larsen,Henrik J. Ditzel	139
15	Development of a specific affinity-matured exosite inhibitor to MT1-MMP that efficiently inhibits tumor cell invasion in vitro and metastasis in vivo 2016 ·Oncotarget ·Kenneth A. Bøtkjær,Hang Fai Kwok,Mikkel G. Terp,Aneesh Karatt-Vellatt,Salvatore Santamaria,John McCafferty,Peter A. Andreasen,Yoshifumi Itoh,Henrik J. Ditzel,Gillian Murphy	34
16	Selection of LNA-containing DNA aptamers against recombinant human CD73 2015 ·Molecular BioSystems ·Ida C. Elle,Kasper K. Karlsen,Mikkel G. Terp,Niels Larsen,Ronni Nielsen,(unknown),Susanne Mandrup,Henrik J. Ditzel,Jesper Wengel	33
17	Ectopic expression of cancer/testis antigen SSX2 induces DNA damage and promotes genomic instability 2014 ·Molecular Oncology ·(unknown),(unknown),Mikkel G. Terp,Christina B. Pedersen,Steffen Schmidt,Jan Mollenhauer,(unknown),Rikke Sick Andersen,(unknown),Henrik J. Ditzel,Morten F. Gjerstorff	33
18	Identification of markers associated with highly aggressive metastatic phenotypes using quantitative comparative proteomics. 2013 ·PubMed ·Mikkel G. Terp,Rikke Raaen Lund,Ole N. Jensen,Rikke Leth‐Larsen,Henrik J. Ditzel	20
19	Functional Heterogeneity within the CD44 High Human Breast Cancer Stem Cell-Like Compartment Reveals a Gene Signature Predictive of Distant Metastasis 2012 ·Molecular Medicine ·Rikke Leth‐Larsen,Mikkel G. Terp,(unknown),Daniel Eliáš,(unknown),Ole N. Jensen,Ole W. Petersen,Henrik J. Ditzel	71
20	Quantitative proteomics of primary tumors with varying metastatic capabilities using stable isotope‐labeled proteins of multiple histogenic origins 2012 ·PROTEOMICS ·Rikke Raaen Lund,Mikkel G. Terp,Anne‐Vibeke Lænkholm,Ole N. Jensen,Rikke Leth‐Larsen,Henrik J. Ditzel	18

About Mikkel G. Terp

Mikkel G. Terp is a scholar working on Cancer Research, Physiology and Immunology, having authored 42 papers that have together received 1.2k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (6 papers), RNA Interference and Gene Delivery (5 papers) and Peptidase Inhibition and Analysis (4 papers). The work is most often cited by research in Cancer Research (342 citations), Physiology (91 citations) and Oncology (404 citations). Mikkel G. Terp has collaborated with scholars based in Denmark, Australia and Sweden. Frequent co-authors include Henrik J. Ditzel, Rikke Leth‐Larsen, Sidse Ehmsen, Rikke Raaen Lund, Ole N. Jensen, Morten F. Gjerstorff, B. Christoffer Lagerholm, Eva C. Arnspang, Guisong Wang and Thomas P. Conrads. Their work appears in journals such as Nucleic Acids Research, Nature Communications and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact